← Evidence map

ReviewCancer2025

Olverembatinib in chronic myeloid leukemia-Review of historical development, current status, and future research.

Hagop Kantarjian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2025
2026
this paperpooled itcites it

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 40197896